Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith Ahamad

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Public Health Reports (Washington, D.C. : 1974)|June 3, 2016
The Impact of Benzodiazepine Use on Mortality Among Polysubstance Users in Vancouver, CanadaGeoffrey R T Walton, Kanna Hayashi, Paxton Bach, et al.
Contemporary Clinical Trials|April 9, 2018
The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationaleM Eugenia Socias, Keith Ahamad, Bernard Le Foll, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 17, 2018
Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl OverdoseFrank X Scheuermeyer, Eric Grafstein, Jane Buxton, et al.
Substance Abuse|January 29, 2019
In-hospital training in addiction medicine: A mixed-methods study of health care provider benefits and differencesLauren Gorfinkel, Jan Klimas, Breanne Reel, et al.
BMJ Open|December 18, 2019
Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping reviewPamela Leece, Triti Khorasheh, Kimberly Corace, et al.
CJEM|August 22, 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packsKevin Duncan, Frank Scheuermeyer, Daniel Lane, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
The American Journal of Psychiatry|June 15, 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled TrialDidier Jutras-Aswad, Bernard Le Foll, Keith Ahamad, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Public Health Reports (Washington, D.C. : 1974)|June 3, 2016
The Impact of Benzodiazepine Use on Mortality Among Polysubstance Users in Vancouver, CanadaGeoffrey R T Walton, Kanna Hayashi, Paxton Bach, et al.
Contemporary Clinical Trials|April 9, 2018
The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationaleM Eugenia Socias, Keith Ahamad, Bernard Le Foll, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 17, 2018
Safety of a Modified Community Trailer to Manage Patients with Presumed Fentanyl OverdoseFrank X Scheuermeyer, Eric Grafstein, Jane Buxton, et al.
Substance Abuse|January 29, 2019
In-hospital training in addiction medicine: A mixed-methods study of health care provider benefits and differencesLauren Gorfinkel, Jan Klimas, Breanne Reel, et al.
BMJ Open|December 18, 2019
Barriers and facilitators to buprenorphine use for opioid agonist treatment: protocol for a scoping reviewPamela Leece, Triti Khorasheh, Kimberly Corace, et al.
CJEM|August 22, 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packsKevin Duncan, Frank Scheuermeyer, Daniel Lane, et al.
Addiction (Abingdon, England)|January 7, 2017
Feasibility and safety of extended-release naltrexone treatment of opioid and alcohol use disorder in HIV clinics: a pilot/feasibility randomized trialPhilip T Korthuis, Paula J Lum, Pamela Vergara-Rodriguez, et al.
The American Journal of Psychiatry|June 15, 2022
Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled TrialDidier Jutras-Aswad, Bernard Le Foll, Keith Ahamad, et al.
Pageof 4